#obesity treatment
Related Stories (2)
New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs
A third of the weight loss from obesity jabs can come from muscle, say experts.
June 8, 2026Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out - Reuters
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out Reuters
February 23, 2026Related Pages (3)
Ozempic butt: Drug to stop muscle loss side effect of obesity jabs
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that's been linked to flat bums or "Ozempic butt", according to research in Nature Medicine journal. Arou
Novo Nordisk vuelve a hundirse en Bolsa al fallar los ensayos de su nuevo medicamento contra la obesidad
La acción cae más del 16% y se deja ya un 75% desde mediados de 2024. El grupo danés se queda por detrás de su rival estadounidense Eli Lilly Enésimo desplome de Novo Nordisk en Bolsa. Sus acciones s
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out
Feb 23 (Reuters) - Novo Nordisk shares slumped by more than 16% on Monday, wiping away the remaining gains brought by its blockbuster weight-loss drug Wegovy, after the drugmaker said its next-gener